Internal Medicine · New York, NY
NPI
1659344653
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
31 Washington Sq West
New York, NY, 10011
Phone (212) 475-8833
Groups this clinician bills Medicare through
Medicare paid, 2024
$244K
3,009 services
Medicare patients, 2024
606
Average age 75
Drug cost, 2024
$1.5M
1,922 prescriptions
Company payments, 2025
$5,053
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph O Rahimian was code 99232 (hospital e&m - subsequent), 999 times for 225 patients. In total Joseph O Rahimian billed 3,009 services in 39 codes, and Medicare paid $244K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 999 | 225 | $67.91 | $68K |
| 99214 Office E&M - Established | Office | 552 | 284 | $100.15 | $55K |
| 99213 Office E&M - Established | Office | 307 | 178 | $60.80 | $19K |
| 99222 Hospital E&M - Initial | Facility | 236 | 211 | $113.28 | $27K |
| 99233 Hospital E&M - Subsequent | Facility | 131 | 67 | $102.19 | $13K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 100 | 100 | $143.45 | $14K |
| 99231 Hospital E&M - Subsequent | Facility | 70 | 45 | $42.88 | $3,002 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 68 | 62 | $13.52 | $919 |
| G0008 Administration of influenza virus vaccine | Office | 64 | 64 | $36.26 | $2,321 |
| 90653 Vaccine Product | Office | 61 | 61 | $81.82 | $4,991 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 55 | 55 | $21.08 | $1,159 |
| 90480 Vaccine Administration | Office | 54 | 52 | $48.35 | $2,611 |
| 91320 Vaccine Product | Office | 54 | 52 | $150.98 | $8,153 |
| 93000 Electrocardiogram | Office | 40 | 37 | $11.83 | $473 |
| 99215 Office E&M - Established | Office | 38 | 30 | $150.10 | $5,704 |
By year: 2022 $168K for 2,011 services; 2023 $227K for 2,625 services; 2024 $244K for 3,009 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph O Rahimian prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 100 prescriptions and refills. In total Joseph O Rahimian wrote 1,922 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 100 | 110 | 14 | $435K |
| Amlodipine Besylate Generic | 75 | 171 | 18 | $680 |
| Atorvastatin Calcium Generic | 72 | 142 | 16 | $512 |
| Isentress Raltegravir Potassium | 72 | 72 | Under 11 | $141K |
| Valacyclovir Valacyclovir Hcl | 62 | 70 | 12 | $1,366 |
| Rosuvastatin Calcium Generic | 46 | 68 | Under 11 | $296 |
| Losartan Potassium Generic | 46 | 81 | Under 11 | $326 |
| Clonazepam Generic | 41 | 41 | Under 11 | $103 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 38 | 38 | Under 11 | $145K |
| Descovy Emtricitabine/Tenofov Alafenam | 37 | 43 | Under 11 | $92K |
| Tivicay Dolutegravir Sodium | 36 | 36 | Under 11 | $81K |
| Ertapenem Ertapenem Sodium | 35 | 35 | 14 | $23K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 34 | 34 | Under 11 | $117K |
| Tamsulosin Hcl Generic | 33 | 53 | Under 11 | $280 |
| Lisinopril Generic | 32 | 96 | Under 11 | $263 |
Brand drugs: - claims; generic drugs: 1,313 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph O Rahimian $5,053 ($5,053 in general payments such as food, travel and fees) from 18 companies. The largest payer was Gilead Sciences, Inc. with $2,734.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 42 | $2,734 |
| ViiV Healthcare Company GSK | 63 | $1,273 |
| Abbvie Inc. ABBV | 18 | $279 |
| Merck Sharp & Dohme LLC MRK | 8 | $236 |
| Shionogi Inc 4507.T | 7 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $57.99 |
| Aimmune Therapeutics, Inc. | 2 | $52.76 |
| Pfizer Inc. PFE | 2 | $47.68 |
| Corium, LLC | 1 | $31.28 |
| Cleerly, Inc. | 1 | $30.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.